Echosens Shares BlueCross BlueShield of Tennessee Medical Policy Update Clarifying Coverage for FibroScan® and Other Noninvasive Elastography Technologies

Echosens said BlueCross BlueShield of Tennessee revised its medical policy for noninvasive imaging in chronic liver disease, effective July 31, 2026. The update is described as a continuation of the insurer’s coverage framework under the new policy, with no disclosed financial figures or major change in utilization.

Analysis

Echosens said BlueCross BlueShield of Tennessee revised its medical policy for noninvasive imaging in chronic liver disease, effective July 31, 2026. The update is described as a continuation of the insurer’s coverage framework under the new policy, with no disclosed financial figures or major change in utilization.